Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12599559 | CD1d-ligand-compound-containing liposome preparation having improved pharmacokinetics | 🖼🧊📄§ | 2026-04-14 | 2041-12-02 | 0 | 31 |
| 12599580 | Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same | 🖼🧊📄§ | 2026-04-14 | 2042-05-05 | 0 | 31 |
| 12599592 | Therapeutic small molecules for treatment of pulmonary hypertension | 🖼🧊📄§ | 2026-04-14 | 2041-11-09 | 0 | 31 |
| 12599570 | Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method | 🖼🧊📄§ | 2026-04-14 | 2042-02-16 | 0 | 31 |
| 12599564 | Antidiabetic pharmaceutical compositions | 🖼🧊📄§ | 2026-04-14 | 2043-05-10 | 0 | 31 |
| 12599556 | Ophthalmic compositions | 🖼🧊📄§ | 2026-04-14 | 2042-02-10 | 0 | 31 |
| 12599558 | Tailored liposomes for the treatment of bacterial infections | 🖼🧊📄§ | 2026-04-14 | 2042-09-30 | 0 | 31 |
| 12599596 | Anti-tumor pharmaceutical composition based on immune checkpoint blockade and use thereof | 🖼🧊📄§ | 2026-04-14 | 2044-11-21 | 0 | 31 |
| 12599588 | Inhibitor for V-ATPase activity, antibacterial agent, medicine, antibacterial method and screening method | 🖼🧊📄§ | 2026-04-14 | 2040-01-15 | 0 | 31 |
| 12599568 | Softgel capsules having a fill composition comprising magnesium oxide | 🖼🧊📄§ | 2026-04-14 | 2043-04-05 | 0 | 31 |
| 12599554 | Pharmaceutical formulations comprising tadalafil | 🖼🧊📄§ | 2026-04-14 | 2041-07-28 | 0 | 31 |
| 12599615 | Use of carotenoids in the treatment of senescence-related diseases | 🖼🧊📄§ | 2026-04-14 | 2040-03-04 | 0 | 31 |
| 12599614 | Methods and pharmaceutical compositions for the treatment and prophylaxis of microbial infectious diseases and associated inflammatory disorders and for the treatment and prophylaxis of aging and associated diseases | 🖼🧊📄§ | 2026-04-14 | 2041-12-13 | 0 | 31 |
| 12600944 | Multiplex genome editing of immune cells to enhance functionality and resistance to suppressive environment | 🖼🧊📄§ | 2026-04-14 | 2039-11-27 | 0 | 31 |
| 12599662 | Methods and compositions for treating cancers | 🖼🧊📄§ | 2026-04-14 | 2039-08-06 | 0 | 31 |
| 12600794 | 5T4 binding polypeptides and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2045-07-21 | 0 | 31 |
| 12600964 | Compound for treatment of heart failure | 🖼🧊📄§ | 2026-04-14 | 2041-11-17 | 0 | 31 |
| 12599634 | Nerve guidance conduit comprising neural crest stem-like cells and/or Schwann cell precursor-like cells and methods of making and using the same | 🖼🧊📄§ | 2026-04-14 | 2042-09-22 | 0 | 31 |
| 12599548 | Method of treating oxidative stress in skin and compositions therefor | 🖼🧊📄§ | 2026-04-14 | 2044-06-04 | 0 | 31 |
| 12599651 | Pharmaceuticals and dosing means for human aging reversal | 🖼🧊📄§ | 2026-04-14 | 2043-07-03 | 0 | 31 |
| 12600987 | Compositions and methods for circular RNA expression | 🖼🧊📄§ | 2026-04-14 | 2041-04-01 | 0 | 31 |
| 12599598 | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-06-08 | 0 | 31 |
| 12599661 | Immunogenic compositions of hepatitis c virus and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2042-12-12 | 0 | 31 |
| 12599700 | System and methods for connective tissue repair using scaffolds | 🖼🧊📄§ | 2026-04-14 | 2040-02-02 | 0 | 31 |
| 12599645 | Antibodies which bind to lysophosphatidic acid receptor 1 (LPAR1) | 🖼🧊📄§ | 2026-04-14 | 2042-09-02 | 0 | 31 |
| 12599672 | KRAS proteolysis targeting chimeras | 🖼🧊📄§ | 2026-04-14 | 2044-10-02 | 0 | 31 |
| 12599562 | Nanocrystal microparticles of poorly soluble drugs and methods of production and use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-12-22 | 0 | 31 |
| 12599582 | Pyrrole compounds | 🖼🧊📄§ | 2026-04-14 | 2043-08-22 | 0 | 31 |
| 12599611 | Methods and compositions for treating seizure disorders in pediatric patients | 🖼🧊📄§ | 2026-04-14 | 2042-06-10 | 0 | 31 |
| 12599600 | Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity | 🖼🧊📄§ | 2026-04-14 | 2041-05-26 | 0 | 31 |
| 12600800 | Therapeutic use of mitochondria and combined mitochondrial agents | 🖼🧊📄§ | 2026-04-14 | 2042-10-06 | 0 | 31 |
| 12600696 | Aromatic compounds | 🖼🧊📄§ | 2026-04-14 | 2042-12-12 | 0 | 31 |
| 12600742 | Markers, conjugates, compositions and methods for hypoxia imaging, mapping, and therapy | 🖼🧊📄§ | 2026-04-14 | 2038-09-19 | 0 | 31 |
| 12599566 | Titanium dioxide free white film coating composition, process for preparing the same and method of use thereof | 🖼🧊📄§ | 2026-04-14 | 2040-09-25 | 0 | 31 |
| 12600791 | Bispecific antibody, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-04-14 | 2039-12-17 | 0 | 31 |
| 12599675 | Conjugate of immune-stimulating il-2 analog and preparation method thereof | 🖼🧊📄§ | 2026-04-14 | 2042-03-31 | 0 | 31 |
| 12601542 | Lyophilized reagents | 🖼🧊📄§ | 2026-04-14 | 2040-12-15 | 0 | 31 |
| 12600716 | Compounds for modulating activity of FXR and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-10-12 | 0 | 31 |
| 12600755 | Cobra 1/NELF-B as a booster for efficacy of CD8+ T cell-based therapy | 🖼🧊📄§ | 2026-04-14 | 2041-02-25 | 0 | 31 |
| 12599601 | Antifungal composition containing carbazole compound as active ingredient | 🖼🧊📄§ | 2026-04-14 | 2040-10-16 | 0 | 31 |
| 12599579 | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids | 🖼🧊📄§ | 2026-04-14 | 2045-07-07 | 0 | 31 |
| 12599606 | Therapies with 3rd generation EGFR tyrosine kinase inhibitors | 🖼🧊📄§ | 2026-04-14 | 2043-08-22 | 0 | 31 |
| 12599603 | Methods of treatment | 🖼🧊📄§ | 2026-04-14 | 2040-09-03 | 0 | 31 |
| 12599617 | Methods of treating head and neck cancers with hemp extract | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12599571 | Method for preparing polydopamine nanomotor using urease, and use of same | 🖼🧊📄§ | 2026-04-14 | 2040-03-10 | 0 | 31 |
| 12599658 | Hepatitis B virus-specific T cell responses | 🖼🧊📄§ | 2026-04-14 | 2040-06-05 | 0 | 31 |
| 12600771 | Antibody for binding to interleukin 4 receptor | 🖼🧊📄§ | 2026-04-14 | 2043-11-15 | 0 | 31 |
| 12599602 | Methods for treating cholestasis | 🖼🧊📄§ | 2026-04-14 | 2044-01-25 | 0 | 31 |
| 12600729 | New-type benzazepine fused ring derivative | 🖼🧊📄§ | 2026-04-14 | 2042-03-04 | 0 | 31 |
| 12599635 | Compositions and treatments for ischemic injuries | 🖼🧊📄§ | 2026-04-14 | 2041-03-22 | 0 | 31 |